Profile image of Philippe Lemaitre, MD
Philippe Lemaitre, MD
Surgical Director, Lung Transplant Program

Call (212) 305-3408 for appointments.

About Philippe Lemaitre, MD:

Philippe Lemaitre, MD, PhD, is a thoracic surgeon specializing in lung transplantation and ECMO procedures. Dr. Lemaitre is known for his patient-centered care and collaborative approach to surgical practice.

After receiving his medical degree from the Free University of Brussels, Dr. Lemaitre underwent residency and graduated PhD in transplant immunology before becoming an attending surgeon at the Erasme Hospital in Brussels, Belgium. He thereafter completed several advanced specialty fellowships at the Toronto General Hospital in Canada.

At Columbia, Dr. Lemaitre primarily focuses on the surgical aspects of lung failure that are lung transplantation and ECMO surgeries. He is part of the Surgical Emphysema Program and the surgical director of the Lung Transplantation Program. Skilled in collaborative care, Dr. Lemaitre’s practice emphasizes a multi-specialty approach to thoracic conditions.

Expertise:

Extracorporeal Membrane Oxygenation (ECMO)
Thoracic Surgery
Thoracic and Cardiac Surgery

Appointments:

Assistant Professor of Surgery at CUMC

New Patients:

YES

Locations

Primary Locations:

CUIMC/Herbert Irving Pavilion

161 Fort Washington Avenue
New York, NY 10032

For new and current patient appointments, call:
(212) 305-3408

Other Locations:

CUIMC/Milstein Hospital Building

177 Ft. Washington Avenue
New York, NY 10032

Insurances:

Please contact the doctor's office directly to verify that your particular insurance is accepted.

AETNA [Student Health, Aetna Signature Administrators, NYP Employee Plan, NY Signature]
Affinity Health Plan [Medicaid Managed Care]
CIGNA [HMO, PPO, Great West (National), Medicare Managed Care, EPO, POS, POS, POS]
Emblem/GHI [Medicare Managed Care, PPO]
Emblem/HIP [POS, EPO, PPO, HMO, Essential Plan, Select Care (Exchange), ConnectiCare, Medicare Managed Care, Vytra, ConnectiCare, PPO, PPO]
Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Medicaid Managed Care, Essential Plan]
Empire Blue Cross/Blue Shield [Medicare Managed Care, Medicare Managed Care, Medicare Managed Care, Medicare Managed Care, Medicare Managed Care, Medicare Managed Care, EPO]
Fidelis Care [Medicaid Managed Care, Medicare Managed Care]
Healthfirst [Medicaid Managed Care, Medicare Managed Care, Child/Family Health Plus, Leaf (Exchange)]
Local 1199 [Local 1199, Local 1199]
MVP Health Care [Essential Plan, Medicaid Managed Care, Essential Plan, Child/Family Health Plus, Medicaid Managed Care, Child/Family Health Plus]
MagnaCare (National) [MagnaCare, MagnaCare]
Medicare [Traditional Medicare, Railroad]
Multiplan [Multiplan, Multiplan]
Quality Health Management [Quality Health Management]
RiverSpring [Special Needs]
UnitedHealthcare [PPO, HMO, POS, Compass (Exchange), Empire Plan, Medicaid (Community Plan), Oxford Freedom, Oxford Liberty, Oxford HMO, HMO]
VNSNY CHOICE [Special Needs, SelectHealth]
WellCare [New Jersey Services (Medicaid Managed Care), Medicare Managed Care]
World Trade Center Health Plan [World Trade Center Health Plan]

Publications:

Uniportal Video-Assisted Transcervical Thymectomy. Philippe H. Lemaître, Shaf Keshavjee. Thorac Surg Clin 29 (2019) 187-194.

Endoscopic Management of Persistent Chylothorax after Esophagectomy for Cancer. Tulelli B, Lemaître P, Farinella E, Devière J, El Nakadi I. JSM Surg Oncol Res 2017, 2(2):1014.

The cholinergic anti-inflammatory pathway delays TLR-induced skin allograft rejection in mice: cholinergic pathway modulates alloreactivity. Sadis C, Detienne S, Vokaer B, Charbonnier LM, Lemaître P, Spilleboudt C, Delbauve S, Kubjak C, Flamand V, Field KA, Goldm an M, Benghiat FS, Le Moine A.PLoS One. 2013 Nov 21;8(11): e79984.

IL-17A and IL-2-expanded regulatory T cells cooperate to inhibit Th1-mediated rejection of MHC II disparate skin grafts. Vokaer B, Charbonnier LM, Lemaître PH, Spilleboudt C, Le Moine A. PLoS One. 2013 Oct 11;8(10):e76040.

IL-17A Mediates Early Post-Transplant Lesions after Heterotopic Trachea Allotransplantation in Mice Philippe H. Lemaître, Benoît Vokaer, Louis-Marie Charbonnier, Yoichiro Iwakura, Marc Estenne, Michel Goldman, Oberdan Leo, Myriam Remmelink, Alain Le Moine. PLOS ONE 10.1371/journal.pone.0070236

Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Lemaître PH, Vokaer B, Charbonnier LM, Iwakura Y, Field KA, Estenne M, Goldman M, Leo O, Remmelink M, Le Moine A. Am J Transplant. 2013 Mar;13(3):611-20

Impact of interleukin-2-expanded regulatory T cells in various allogeneic combinations on mouse skin graft survival. Vokaer B, Charbonnier LM, Lemaître PH, Le Moine A. Transplant Proc. 2012 Nov; 44(9):2840-4.

CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Charbonnier LM, Vokaer B, Lemaître PH, Field KA, Leo O, Le Moine A. Am J Transplant. 2012 Sep;12(9):2313-21

Etude des mécanismes dépendants de l'interleukine-17 et de leur modulation dans le développement de la bronchiolite oblitérante expérimentale après transplantation. Lemaître P. Bull Mem Acad R Med Belg. 2010;165(7-9):367-71.

Critical role of regulatory T cells in Th17- mediated minor antigen-disparate rejection. B Vokaer, N van Rompaey, Ph Lemaître, F Lhommé, C Kubjak, FS Benghiat, Y Iwakura, M Petein, KA Field, M Goldman, A Le Moine and LM Charbonnier. J Immunol. 2010 Sep 15;185(6):3417-25.

How should we treat mucinous appendiceal neoplasm? By laparoscopy or laparotomy? A case report. Liberale G, Lemaître P, Noterman D, Moerman C, de Neubourg E, Sirtaine N, El Nakadi I. Acta Chir Belg. 2010 Mar-Apr;110(2):203-7.

Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1.V De Wilde, N Van Rompaey, M Hill, JF Lebrun, Ph Lemaître, F Lhommé, C Kubjak, B Vokaer, G Oldenhove, LM Charbonnier, MC Cuturi, M Goldman, A Le Moine. Am J Transplant. 2009 Sep;9(9):2034-47

Chylorrhea after axillary lymph node dissection. Sales F, Trepo E, Brondello S, Lemaître P, Bourgeois P. Eur J Surg Oncol. 2007 Oct; 33(8):1042-3